Latest Healthcare in India Stories
ALISO VIEJO, Calif., April 5, 2011 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that company management will present an overview of the company at the Future Leaders in the Biotech Industry Conference in New York City.
CALGARY, March 31 /PRNewswire-FirstCall/ - Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc. (TSX: ONC) (NASDAQ: ONCY), will present a corporate overview of the Company at the 10(th) Annual Needham Healthcare Conference on Tuesday, April 5(th), 2011 at 10:00 a.m. ET.
In this week's PLoS Medicine, K. Srinath Reddy from the Public Health Foundation of India discusses new research published last week by Malavika Subramanyam, S V Subramanian, and colleagues that found no link between economic growth and child undernutrition rates in India, concluding that direct investments in appropriate health interventions may be necessary to improve child health in India.
LOS ANGELES, March 7, 2011 /PRNewswire/ -- Genesis Biopharma, Inc. (OTC Bulletin Board: GNBP), a biotechnology company developing targeted cancer therapies, today announced it has named Marvin S. Hausman M.D. as Chief Science Officer. Dr.
CALGARY, March 3 /PRNewswire-FirstCall/ - Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc. (TSX: ONC) (NASDAQ: ONCY), will present a corporate overview of the Company at the 31(st) Annual Cowen and Company Healthcare Conference on Tuesday, March 8(th), 2011 at 8:45 a.m. ET.
SAN DIEGO, March 2, 2011 /PRNewswire/ -- Cadence Pharmaceuticals, Inc.
HONG KONG, March 1 /PRNewswire/ - Today, www.WorldStreetFundamentals.com released its industry report highlighting Keryx Biopharmaceuticals (NASDAQ: KERX) and Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ).
JERUSALEM, February 28, 2011 /PRNewswire-FirstCall/ -- Oramed Pharmaceuticals Inc. (OTCBB: ORMP), a developer of oral drug delivery systems, announced today that its subsidiary Oramed Ltd. entered into a Share Purchase Agreement with D.N.A Biomedical Solutions Ltd.
SAN DIEGO, Feb. 25, 2011 /PRNewswire/ -- Cadence Pharmaceuticals, Inc.
CALGARY, Feb. 24 /PRNewswire/ - Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc. (TSX: ONC) (NASDAQ: ONCY), will participate in a panel discussion at the RBC Capital Markets Healthcare Conference on Wednesday, March 2(nd), 2011 at 9:00 a.m. ET.